Picato Gel for Picato Gel: 0.015%
Picato Gel for Picato Gel: 0.015% is a brand of medicine containing the active ingredient ingenol mebutate.
Find out more about active ingredients.
Consumer medicine information (CMI) leaflet
Developed by the pharmaceutical company responsible for this medicine in Australia, according to TGA regulations.
Picato® gel, 0.015%
Ingenol (in' jen ol) mebutate (me bue' tate)
Consumer Medicine Information
Please read this leaflet carefully before you start your treatment.
Picato® gel, 0.015% is the brand name. The generic name of the active ingredient is ingenol mebutate.
Keep this leaflet. You may want to read it again.
What is in this leaflet?
This leaflet answers some common questions about using the medicine Picato® gel, 0.015%. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you using Picato® gel against the benefits it is expected to have for you.
If you have any concerns about using Picato® gel talk to your doctor or pharmacist.
What Picato® gel, 0.015% is used for
Picato® gel, 0.015% is used as a topical treatment of solar keratoses (sun spots) on the face and scalp of adults.
Solar keratoses are thickened, scaly patches of skin caused by too much sun exposure. Solar keratoses are also known as actinic keratoses.
Picato® gel contains the active ingredient ingenol mebutate.
The ingenol mebutate in Picato® gel treats the lesions in the area where the gel is applied.
USE PICATO® GEL 0.015% ON YOUR FACE AND SCALP
IT IS NOT RECOMMENDED THAT PICATO® GEL, 0.015% IS USED ON OTHER PARTS OF YOUR BODY
Picato® gel is only available with a doctor’s prescription.
This medicine is not expected to affect your ability to drive a car or operate machinery.
This medicine is not addictive.
Before you use Picato® gel
When you must not use Picato® gel
Do not use Picato® gel, if you are allergic to ingenol mebutate or any of the other ingredients listed at the end of this leaflet (see Product description).
Some of the symptoms of an allergic reaction include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or “hives” on the skin.
Do not use Picato® gel, on broken skin
Do not use Picato® gel
- after the expiry date printed on the pack OR
- if the packaging is torn, doesn’t look quite right or shows signs of tampering.
If any of these apply, return the medicine to your pharmacist for disposal.
If you are not sure whether you should start using Picato® gel, talk to your doctor.
Before you start to use Picato® gel
Tell your doctor if you have a known allergy to Picato® gel ingenol mebutate or any of the ingredients listed at the end of this leaflet
Tell your doctor if you
- are pregnant or intend to become pregnant.
- are taking any other medicines
- currently have, or in the past have had, any other medical conditions.
Do not use Picato® gel on children. Solar keratoses is not a condition that normally affects children. Safety and effectiveness of Picato® gel in those below 18 years of age has not been established.
If you have not told your doctor about any of the above, tell him/her before you start using this medicine.
Tell your doctor or pharmacist if you are using any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food store.
Your doctor and pharmacist have more information on medicines you should be careful with or avoid whilst using Picato® gel.
How to use Picato® gel, 0.015%
Follow carefully all directions given to you by your doctor or pharmacist. They may differ from the information contained in this leaflet.
If you do not understand the instructions in this leaflet, ask your doctor or pharmacist for help.
How much Picato® gel, 0.015% to use
Each carton of Picato® gel, 0.015% contains 3 small tubes.
Each tube of Picato® gel, 0.015% contains a single dose. You should apply the contents of 1 tube to the area on your face or scalp containing the sun spot (s) / lesion(s).
Each tube of Picato® gel, 0.015% contains enough gel to cover an area of approximately 25cm2 (e.g. 5cm x 5cm). However, avoid getting Picato® gel close to the eye area, nostrils and mouth. If the lesion is near the eye area, nostrils or mouth you may need to apply Picato® gel to a smaller treatment area.
How to use Picato® gel, 0.015%
Apply Picato® gel, 0.015% only to treatment areas on the face or scalp.
Use Picato® gel, 0.015% as follows:
- Squeeze the gel from the single use tube onto the fingertip and then spread it evenly over the treatment area
- Allow treatment area to dry for 15 minutes. Do not touch during this time.
- Wash your hands with soap and water immediately after application
- Do not wash the area of the body where Picato® gel, 0.015% was applied for at least 6 hours after application
- After this period the treatment area may be washed using mild soap and water.
- Picato® gel, 0.015% should not be applied immediately before or after taking a shower as the skin needs to be very dry before application
- Picato® gel, 0.015% should not be applied less than 2 hours before bedtime
- The area treated with Picato® gel, 0.015% should not be covered with occlusive bandages.
The full effects of Picato® gel 0.015% are best assessed approximately 8 weeks after treatment.
How long to use Picato® gel
A treatment course lasts for 3 days.
Apply Picato® gel, 0.015% once a day for 3 days in a row.
If you forget to use Picato® gel
If you forget to apply the second or third tube of Picato® gel within 3 days of the last application, apply the second or third tube when you remember If it has been more than 3 days since the last application, do not apply the remaining tube(s). If this happens you should contact your doctor.
If you are not sure what to do, ask your doctor or pharmacist.
If you use too much or use it other than directed (Overdose)
If you use too much or use it other than directed (Overdose) immediately telephone your doctor or the Poisons Information Centre (Telephone 13 11 26 in Australia or 0800 764 766 in New Zealand) for advice, or go to the Emergency Department at the nearest hospital, if you think that you or anyone else may have used too much or swallowed some of this medicine. Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention
While you are using Picato® gel
Things you must do
While you are using Picato® gel you should protect the treated skin areas from sunlight and ultraviolet (UV) rays. This can be done by covering the treated area with clothing before going outside. Sunscreen can be applied to the treatment site once treatment is completed and the treatment area has healed.
Non-medicated, non-irritant products can also be applied to the treatment area once treatment is completed and the treatment area has healed.
If you are going to start any new medicine, tell your doctor and pharmacist that you are using Picato® gel.
If you become pregnant while using Picato® gel tell your doctor immediately.
If you experience an allergic reaction whilst you are using Picato® gel, stop using it, and immediately seek medical attention
Keep all appointments with your doctor so that your progress can be checked.
Things you must not do
Do not give your medicine to anyone else, even if they have the same condition as you.
Do not use more than the recommended daily dose (see How to use Picato® gel, 0.015%).
DO NOT APPLY PICATO® GEL TO OR NEAR YOUR EYE AREA.
Avoid contact with, or accidental transfer to, the eye area during or after treatment.
If it gets into your eyes or your eye area, flush with plenty of water then consult your doctor immediately.
As with all medicines, Picato® gel can cause some side effects.
The most common effects are expected and show that the treatment is working.
The expected effects at the application site include:
- Skin reddening
- Skin flaking or scaling
- Mild swelling
- Crusting or Scabbing
Swelling at the application site may extend to the eye area.
Side effects not listed above may also occur in some people. These less common side effects include:
- Ulceration of the treatment site.
All these effects usually clear within 2 weeks. If the effects continue for longer you should talk to your doctor.
Tell your doctor or pharmacist if you notice the following side effects:
- Ulcers forming
- Skin weeping
- Swelling of the eye area
- You think the application site has become infected.
You should also tell your doctor or pharmacist if you have any additional unpleasant effects while you are using Picato® gel.
After using Picato® gel
Keep Picato® gel in the box in the refrigerator until required.
STORE PICATO® GEL IN THE REFRIGERATOR.
Picato® gel can spend a short time outside of the refrigerator if the temperature is below 30°C. This will allow you time to get Picato® gel home from the pharmacy and into the refrigerator.
Periods of storage outside of the refrigerator may reduce the effectiveness of Picato® gel.
Store Picato® gel where children cannot reach it.
Ask your pharmacist what to do with Picato® gel that is left over if:
- your doctor tells you to stop using Picato® gel
- the expiry date has passed
What it looks like
Picato® gel is a clear, colourless
Picato® gel contains the active ingredient ingenol mebutate.
It also contains:
- isopropyl alcohol,
- citric acid monohydrate,
- sodium citrate,
- benzyl alcohol
The Australian Registration Number is AUST R 190122
This is not all the information available on Picato® gel, 0.015%. If you have any more questions or are unsure about anything, ask your doctor or pharmacist.
Picato® gel is supplied in Australia by:
LEO Pharma Pty Ltd,
Level 3, Tower 1, 25 Montpelier Road,
Bowen Hills, QLD 4006,
Picato® gel is supplied in New Zealand by:
LEO Pharma Ltd,
Level 31, Vero Centre, 48 Shortland St, Auckland,
Australia Toll free no: 1800 991 778
New Zealand Toll free no: 0800 497 456
Picato, LEO and LEO/lion device are registered trademarks of LEO Pharma A/S.
This leaflet was prepared in November 2012 and last revised in October 2016.
CMI provided by MIMS Australia, March 2017